Browsing by Author "Nunez, Eduardo"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- Item4th booster-dose SARS-CoV-2 heterologous and homologous vaccination in rheumatological patients(2024) Gallardo-Nelson, Maria Jose; Cruces, Marcos; Gomez, Yolanda M.; Fuenzalida, Constanza; Silva, Javiera; Aravena-Traipi, Laura; Nunez, Eduardo; Gaete-Angel, Aracelly; Rivas-Yanez, Elizabeth; Kalergis, Alexis M.; Soto-Rifo, Ricardo; Valiente-Echeverria, FernandoObjective to evaluate the immune response to the SARS-CoV-2 vaccines in adults with immune-mediated rheumatic diseases (IMRDs) in comparison to healthy individuals, observed 1-20 weeks following the fourth vaccine dose. Additionally, to evaluate the impact of immunosuppressive therapies, vaccination schedules, the time interval between vaccination and sample collection on the vaccine's immune response. Methods We designed a longitudinal observational study conducted at the rheumatology department of Hospital de Copiap & oacute;. Neutralizing antibodies (Nabs) titers against the Wuhan and Omicron variant were analyzed between 1-20 weeks after administration of the fourth dose of the SARS-CoV-2 vaccine to 341 participants (218 IMRD patients and 123 healthy controls). 218 IMRD patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), systemic lupus erythematosus (SLE), systemic vasculitis (VS) and systemic scleroderma (SS) were analyzed. Results Performing a comparison between the variants, Wuhan vs Omicron, we noticed that there were significant differences (p<0.05) in the level of the ID50, both for healthy controls and for patients with IMRDs. The humoral response of patients with IMRDs is significantly lower compared to healthy controls for the Omicron variant of SARS-CoV-2 (p = 0.0015). The humoral response of patients with IMRDs decreases significantly when the time interval between vaccination and sample collection is greater than 35 days. This difference was observed in the response, both for the Wuhan variant and for the Omicron variant. Conclusion The IMRDs patients, the humoral response variation in the SARS-CoV-2 vaccine depends on doses and type of vaccine administered, the humoral response times and the treatment that these patients are receiving.
- ItemNumerical Study on Cyclic Response of End-Plate Biaxial Moment Connection in Box Columns(2020) Gallegos, Marco; Nunez, Eduardo; Herrera, RicardoThe 2008 Wenchuan-China earthquake showed the importance of considering the bidirectional seismic action as a cause of failure in column hinge mechanisms. Subsequently, the large 2011 Tohoku-Japan earthquake revealed that Special Moment Frames buildings, made of tubular columns (Hollow Structural Section or Built-up Box Section) and rigid connections with I-beams, did not suffer serious damage. However, only the ConXtech((R)) ConXL (TM) moment connection has been prequalified according to the (American Institute of Construction) AISC Seismic Provisions for use with tubular columns and the rest of connections do not consider biaxial resistance. The research reported herein investigated the cyclic response of box-columns joints, connected to I beams using the four-bolt extended endplate connection, subjected to bidirectional bending and axial load on the column. To conduct the study, complex nonlinear finite element models (FEMs) of several I beam to box column joint configurations were constructed and analyzed under cyclic loading using the ANSYS software. The results reveal that the failure is concentrated in the beams of all joint configurations except for the columns with axial load equal to 75% of the column capacity, where a combined failure mechanism is achieved. The energy dissipation capacity of joints with a greater number of beams is lower than joints with fewer beams. The bidirectional effect of the seismic action and the level of axial load must be considered to avoid the formation of a column-hinge fragile failure mechanism also the behavior exhibited by 3D joints is more realistic than 2D joints according to real structures.